Therapeutic Asset Ratings

9,920 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Onc 206 Anaplastic Oligodendroglioma	Jazz Pharmaceuticals	P1	CC (43)
Onc 206 Anaplastic Pleomorphic Xanthoastrocytoma	Jazz Pharmaceuticals	P1	CC (43)
Onc 206 Grade II Meningioma	Jazz Pharmaceuticals	P1	CC (43)
Onc 206 Childhood Choroid Plexus Neoplasm	Jazz Pharmaceuticals	P1	CC (43)
Onc 206 Central Nervous System Neoplasm	Sabine Mueller, MD, PhD	P1	CC (43)
Onc 206 Diffuse Astrocytoma	Jazz Pharmaceuticals	P1	CC (43)
Onc 206 Diffuse Midline Glioma, H3 K27M-Mutant	Jazz Pharmaceuticals	P1	CC (43)
Onc 206 Ependymoma	Sabine Mueller, MD, PhD	P1	CC (43)
Onc 206 Anaplastic Ependymoma	Jazz Pharmaceuticals	P1	CC (43)
Onc 206 Glioma	Jazz Pharmaceuticals	P1	CC (43)
Onc 206 Glioblastoma	Sabine Mueller, MD, PhD	P1	CC (43)
Onc 206 Gliomatosis Cerebri	Jazz Pharmaceuticals	P1	CC (43)
Onc 206 Gliosarcoma	Jazz Pharmaceuticals	P1	CC (43)
Onc 206 Medulloblastoma	Jazz Pharmaceuticals	P1	CC (43)
Onc 206 Primitive Neuroectodermal Tumor	Jazz Pharmaceuticals	P1	CC (43)
Onc 206 Pilocytic Astrocytoma	Jazz Pharmaceuticals	P1	CC (43)
Onc 206 Pineal Parenchymal Cell Neoplasm	Jazz Pharmaceuticals	P1	CC (43)
Onc 206 Pleomorphic Xanthoastrocytoma	Jazz Pharmaceuticals	P1	CC (43)
Onc 206 Central Nervous System Cancer	Sabine Mueller, MD, PhD	P1	CC (43)
Onc 206 Spinal Cord Glioma	Sabine Mueller, MD, PhD	P1	CC (43)
Onc 206 Atypical Teratoid Rhabdoid Tumor	Jazz Pharmaceuticals	P1	CC (43)
Onc 206 Grade III Glioma	Sabine Mueller, MD, PhD	P1	CC (43)
Oncolytic Adenovirus Ad5-Dnx-2401 IDH-Wildtype Glioblastoma	M.D. Anderson Cancer Center	P1	CC (43)
Oncolytic Adenovirus Ad5-Dnx-2401 Anaplastic Astrocytoma	M.D. Anderson Cancer Center	P1	CC (43)
Oncolytic Adenovirus Ad5-Dnx-2401 Gliosarcoma	M.D. Anderson Cancer Center	P1	CC (43)

Showing 3626 to 3650 of 9,920 assets

PreviousPage 146 of 397Next